TBRG earnings analysis
What we found in TBRG's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
TruBridge, Inc. reported a slight decrease in total revenue for Q1 2026, totaling $86.3 million, down 1% from $87.2 million in Q1 2025. The diluted EPS for the quarter was $0.03, unchanged from the prior year. Alongside a notable drop in operating income, performance varied across business segments, with Financial Health revenues declining while Patient Care revenues increased due to new SaaS contract growth and increased migration to SaaS models.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Decline
- Total revenue was $86.3 million, a decrease of 1% from $87.2 million in Q1 2025.
- Steady EPS Amid Decline
- Diluted EPS remained flat at $0.03 compared to the same quarter last year.
- Patient Care Growth
- Patient Care revenues grew by 6%, reaching $33.0 million, driven by new SaaS contracts.
- Cash Flow Improvement
- Net cash provided by operating activities increased by $9.7 million to $15.5 million in Q1 2026.
- Cost Optimization
- Total costs of revenue decreased by $1.2 million and improved as a percentage of revenue, to 44%.
- Increased Cash Reserves
- Cash and cash equivalents rose to $35.4 million from $24.9 million at the end of 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Earnings Miss Expectations
- Actual EPS was -$0.37 vs estimated EPS of $0.51, missing expectations by 1.73%.
- Financial Health Segment Decline
- Financial Health revenues fell by 5% to $53.3 million due to customer attrition.
- Pending Merger Risks
- The proposed merger with IKS may not complete, creating uncertainty and operational disruption.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.03
- Gross margin
- 55.5%
- Operating margin
- 3.5%
- Segment
- Financial Health
- Segment
- Patient Care
What they said about what is next.
No explicit forward guidance provided in the filing.
The filing reads worse than the one before it.
What came before.
- 10-K · April 30, 2026
- TruBridge's latest 10-K filing provides insights into its strategic vision and ongoing acquisition by IKS Health, which is anticipated to close in Q3 2026. However, the most recent earnings report revealed an EPS of…
- 10-K · March 31, 2026
- TruBridge reported 2025 revenue of $346.8 million (an increase of $4.6 million, or 1%, versus 2024) and turned profitable with net income of $4.4 million (EPS $0.29) after a 2024 net loss of $20.9 million. The business…
- 10-K · March 17, 2025
- TruBridge reported 2024 revenue of $342.6M (up 2.0% YoY) driven by Financial Health, while Patient Care revenues declined after the sale of AHT. Operating income turned positive at $6.6M and operating cash flow improved…
- 10-Q · November 12, 2024
- TruBridge reported Q3 revenue of $83,830 (in thousands), up $1,118 from $82,712 in the prior-year quarter, driven by Financial Health growth. Operating income improved to $1,944 (in thousands) from an operating loss of…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TBRG makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever